Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Scorpio NRG Prospective, Open-label, Post-market International Multicentre Outcome Study

NCT02524730 is registered in ClinicalTrials.gov with Stryker Orthopaedics as lead sponsor.

NCT NCT02524730
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02524730 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Scorpio NRG Prospective, Open-label, Post-market International Multicentre Outcome Study
Lead sponsor
Stryker Orthopaedics
Phase
Not applicable
Overall status
Completed
Start date
May 18, 2009
Completion date
February 10, 2020
Enrollment
205 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

arthroplasty, replacement, knee